These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1422459)

  • 1. [The correction of disorders in the pharmacodynamics of drugs metabolized in the liver in the postnatal ontogeny of rats with acute hepatitis].
    Khakimov ZZ; Rakhmanov AKh
    Eksp Klin Farmakol; 1992; 55(2):58-9. PubMed ID: 1422459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of ethonium on the status of the liver glutathione system in toxic hepatitis].
    Meshchishen IF
    Farmakol Toksikol; 1989; 52(3):80-2. PubMed ID: 2792361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of phytin, benzonal and their combination administered prophylactically on the pharmacodynamics of drugs metabolized in the liver in hypokinesia].
    Khakimov ZZ; Mavlianov BR; Rakhmanov AKh; Mavlianov IR
    Eksp Klin Farmakol; 1992; 55(6):58-60. PubMed ID: 1305882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis caused by drugs. I].
    Valerdiz Casasola S; Linares Rodríguez A; Recarte Alvarez J; Rodrigo Sáez L
    Rev Esp Enferm Apar Dig; 1982 Jul; 62(1):74-82. PubMed ID: 6753061
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of calcium pangamate on the bile forming and bile secreting function of the liver under normal conditions and in experimental hepatitis].
    Pidemskiĭ EL; Mardanova LG
    Patol Fiziol Eksp Ter; 1971; 15(2):96-7. PubMed ID: 5138389
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of pyrogenal and glucomannan on the liver content of peptides and nucleopeptides and blood protein content in CC14-hepatitis in rats].
    Avramenko MM; Gladyshev BN; Veĭnova MK; Afanas'eva EM
    Vopr Med Khim; 1972; 18(6):627-30. PubMed ID: 4646037
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of vitamin B6 (pyridoxine) on liver glycogen concentration in acute experimental hepatitis].
    Pacechnik IK
    Patol Fiziol Eksp Ter; 1970; 14(1):81-2. PubMed ID: 5453792
    [No Abstract]   [Full Text] [Related]  

  • 8. [The efficacy of hepatoprotective agents in experimental chronic hepatitis].
    Saratikov AS; Vengerovskiĭ ; Baturina NO; Chuchalin VS
    Eksp Klin Farmakol; 1996; 59(1):24-6. PubMed ID: 8704626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An experimental study of the hepatoprotective properties of phytoecdysteroids and nerobol in carbon tetrachloride-induced liver lesion].
    Syrov VN; Khushbaktova ZA; Nabiev AN
    Eksp Klin Farmakol; 1992; 55(3):61-5. PubMed ID: 1458171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The efficacy of hepatoprotectors and cytochrome P-450 inducers in correcting the functional activity of the hepatocyte microsomal system in an acute lesion of the liver in prepuberty].
    Khakimov ZZ; Rakhmanov AKh
    Eksp Klin Farmakol; 1992; 55(4):16-7. PubMed ID: 1458177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of normase on the lipid peroxidation indices in a toxic lesion of the liver].
    Uzbekova DG; Riabkov AN; Artem'eva GB
    Eksp Klin Farmakol; 1993; 56(1):60-2. PubMed ID: 8324482
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of eplir on an experimental toxic lesion of the liver].
    Saratikov AS; Vengerovskiĭ AI; Paul's OV; Sedykh IM
    Farmakol Toksikol; 1990; 53(5):42-5. PubMed ID: 2253748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The antioxidant properties of parmidine in a toxic lesion of the liver].
    Riabkov AN; Uzbekova DG; Artem'eva GB; Nikulin AA
    Farmakol Toksikol; 1991; 54(6):35-7. PubMed ID: 1804692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative study of the effect of hepatoprotectors and inducers on cardiogreen pharmacokinetics in acute toxic hepatitis in the prepuberty period].
    Khakimov ZZ; Rakhmanov AKh
    Eksp Klin Farmakol; 1994; 57(6):57-9. PubMed ID: 7756967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The acetylcysteine correction of disorders of the oxidative processes in a toxic liver lesion].
    Gonskiĭ IaI; Korda MM; Klishch IN; Fira LS
    Eksp Klin Farmakol; 1995; 58(6):64-6. PubMed ID: 8704618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Superoxide dismutase--a prospective hepatoprotective agent].
    Drogovoz SM; Slyshkov VV; Sarbash TF; Sal'nikova SI; Derimedved' LV; Sharonov BP
    Eksp Klin Farmakol; 1993; 56(4):51-2. PubMed ID: 8220019
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of acetylcysteine on the antioxidant system in an experimental toxic lesion of the liver].
    Gonskiĭ IaI; Korda MM; Klishch IN
    Farmakol Toksikol; 1991; 54(5):44-6. PubMed ID: 1800148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New hepatoprotective agents of natural origin].
    Saratikov AS; Vengerovskiĭ AI
    Eksp Klin Farmakol; 1995; 58(1):8-11. PubMed ID: 7787707
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness of lipamide in experimental hepatic dystrophy].
    Posokhova EA
    Farmakol Toksikol; 1979; 42(1):68-71. PubMed ID: 369884
    [No Abstract]   [Full Text] [Related]  

  • 20. [Relation of EPR signals of liver RNA to liver function].
    Naktinis II; Montvilene GV; Margiavichene LE
    Biofizika; 1971; 16(4):728-30. PubMed ID: 4328361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.